Compugen

Compugen Receivables/Revenue

Receivables to Revenue Ratio of Compugen (CGEN) as of Oct 19, 2026.

Receivables/Revenue

0.00

Last updated:

Receivables to Revenue Ratio of Compugen is 2024 0.00 . Receivables to Revenue Ratio of Compugen was 2023 182.31 % . It decreases by % lower compared to the previous year.

The Compugen Receivables/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables/Revenue
Date
Receivables/Revenue
Jan 1, 2014
0.00 USD
Jan 1, 2015
84.08 USD
Jan 1, 2016
0.00 USD
Jan 1, 2020
100.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2023
182.31 USD
Jan 1, 2024
0.00 USD
The Compugen Receivables/Revenue history
YEARReceivables/RevenueYoY
0.00-100.00%
182.31 %—
0.00-100.00%
100.00 %—
0.00-100.00%
84.08 %—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

On Eulerpool you can find the complete historical development of Receivables to Revenue Ratio Compugen since 2006 – with annual values, charts, and detailed analysis.

The Receivables/Revenue ratio shows what percentage of annual revenue is tied up in accounts receivable. Rising ratios may signal collection issues.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Receivables to Revenue Ratio's Compugen with sector peers and the industry average to assess whether it is attractive.

To evaluate Receivables to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Receivables to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Compugen

All Key Metrics — Compugen